IGC PHARMA INC (IGC) Stock Balance Sheet
NYSEARCA:IGC • US45408X3089
Current stock price
0.319 USD
-0.02 (-5.03%)
At close:
0.3266 USD
+0.01 (+2.38%)
After Hours:
| MRQ (2025-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.10M | 405.00K | 1.20M | 3.20M | 10.46M | |||
| Marketable Securities | 25.00K | 38.00K | 0.00 | 150.00K | 0.00 | |||
| Receivables | 61.00K | 77.00K | 91.00K | 130.00K | 600.00K | |||
| Inventories | 658.00K | 1.36M | 1.54M | 2.65M | 3.55M | |||
| Other Current Assets | 155.00K | 1.05M | 876.00K | 330.00K | 510.00K | |||
| Total Current Assets | 2.00M | 2.90M | 3.71M | 6.47M | 15.11M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.19M | 3.32M | 3.89M | 8.54M | 9.87M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 4.88M | 1.85M | 1.62M | 1.17M | 920.00K | |||
| Other Non-Current Assets | 672.00K | 681.00K | 688.00K | 1.00M | 940.00K | |||
| Total Non-Current Assets | 7.74M | 5.85M | 6.20M | 10.71M | 11.72M | |||
| TOTAL ASSETS | 9.74M | 8.75M | 9.90M | 17.18M | 26.83M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.00K | 3.00K | 3.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 407.00K | 254.00K | 940.00K | 750.00K | 1.18M | |||
| Accounts Payable | 628.00K | 883.00K | 773.00K | 530.00K | 980.00K | |||
| Other Current Liabilities | 475.00K | 1.12M | 624.00K | 610.00K | 280.00K | |||
| Total Current Liabilities | 1.51M | 2.26M | 2.34M | 1.90M | 2.44M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 132.00K | 134.00K | 137.00K | 140.00K | 140.00K | |||
| Other Non-Current Liabilities | 5.00K | 26.00K | 104.00K | 230.00K | 360.00K | |||
| Total Non-Current Liabilities | 137.00K | 160.00K | 241.00K | 370.00K | 500.00K | |||
| TOTAL LIABILITIES | 1.65M | 2.42M | 2.58M | 2.27M | 2.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -122.83M | -120.74M | -113.67M | -100.67M | -89.16M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | N/A | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 135.77M | 130.57M | 124.41M | 118.97M | 116.02M | |||
| Other Shareholders' Equity | -4.85M | -3.50M | -3.42M | -3.39M | -2.97M | |||
| Shares Outstanding | 91.96M | 80.88M | 66.69M | 53.08M | 51.05M | |||
| Tangible Book Value per Share | 0.03 | 0.06 | 0.09 | 0.26 | 0.45 | |||
| Total Shareholders' Equity | 8.09M | 6.33M | 7.32M | 14.91M | 23.89M | |||
| TOTAL LIABILITIES AND EQUITY | 9.74M | 8.75M | 9.90M | 17.18M | 26.83M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |||
| Current Ratio | 1.32 | 1.28 | 1.58 | 3.41 | 6.19 | |||
| Return On Assets (ROA) | -61.24% | -81.41% | -131.29% | -67.00% | -55.98% | |||
| Return On Equity (ROE) | -73.74% | -112.50% | -177.57% | -77.20% | -62.87% | |||
All data in USD , ROIC based on taxRate of 0.21